Curcumin Loaded Microsponges for Colon Targeting in Inflammatory Bowel Disease: Fabrication, Optimization, and In Vitro and Pharmacodynamic Evaluation

Table 3

Compilation of various evaluation parameters for curcumin microsponge formulations.

Formulation code	Particle size∗; (μm)	EE (%)∗	PY (%)∗	DL (%)∗
F1	51.06±0.15	70.36±1.23	87.26±0.42	37.71±0.22
F2	54.44±0.96	68.75±0.98	88.89±0.92	40.18±0.56
F3	57.59±0.55	66.12±1.96	74.45±0.74	45.36±0.74
F4	50.14±0.71	76.61±0.84	86.13±1.55	69.45±0.98
F5	52.95±0.22	74.85±0.56	86.39±1.78	40.33±1.20
F6	55.29±0.81	71.19±1.10	80.44±0.71	64.45±0.77
F7	41.63±0.25	78.13±1.45	80.15±0.84	66.94±0.68
F8	45.62±0.69	76.74±0.73	84.72±0.58	47.69±1.73
F9	47.23±0.74	72.58±2.31	71.49±1.19	39.89±0.84

^∗𝑛=3, mean ± S.D.